收费全文 | 1359篇 |
免费 | 137篇 |
国内免费 | 19篇 |
耳鼻咽喉 | 10篇 |
儿科学 | 81篇 |
妇产科学 | 7篇 |
基础医学 | 200篇 |
口腔科学 | 70篇 |
临床医学 | 169篇 |
内科学 | 231篇 |
皮肤病学 | 51篇 |
神经病学 | 38篇 |
特种医学 | 248篇 |
外科学 | 142篇 |
综合类 | 37篇 |
预防医学 | 73篇 |
眼科学 | 18篇 |
药学 | 40篇 |
1篇 | |
肿瘤学 | 99篇 |
2022年 | 8篇 |
2021年 | 12篇 |
2020年 | 14篇 |
2019年 | 13篇 |
2018年 | 23篇 |
2017年 | 11篇 |
2016年 | 13篇 |
2015年 | 29篇 |
2014年 | 28篇 |
2013年 | 49篇 |
2012年 | 33篇 |
2011年 | 44篇 |
2010年 | 59篇 |
2009年 | 62篇 |
2008年 | 36篇 |
2007年 | 42篇 |
2006年 | 33篇 |
2005年 | 32篇 |
2004年 | 21篇 |
2003年 | 33篇 |
2002年 | 23篇 |
2001年 | 19篇 |
2000年 | 13篇 |
1999年 | 31篇 |
1998年 | 86篇 |
1997年 | 78篇 |
1996年 | 59篇 |
1995年 | 54篇 |
1994年 | 38篇 |
1993年 | 46篇 |
1992年 | 9篇 |
1991年 | 26篇 |
1990年 | 21篇 |
1989年 | 52篇 |
1988年 | 47篇 |
1987年 | 33篇 |
1986年 | 23篇 |
1985年 | 23篇 |
1984年 | 16篇 |
1983年 | 15篇 |
1982年 | 15篇 |
1981年 | 16篇 |
1980年 | 17篇 |
1979年 | 10篇 |
1978年 | 20篇 |
1977年 | 15篇 |
1976年 | 20篇 |
1975年 | 12篇 |
1974年 | 11篇 |
1968年 | 7篇 |
To determine whether patients with obstructive sleep apnea (OSA) are at increased risk of occupational injury (OI)
MethodsWorking patients (aged 18 to 65 who reported more than 10 h of work per week) who were referred to the University of British Columbia Sleep Laboratory for suspected OSA for polysomnogram (PSG) were recruited from 2003 to 2011. Patients completed an extensive survey the night of their PSG. Validated OI was obtained by linking patient data to Workers Compensation Board Claims Data.
Results1109 workers were studied; mean age was 47.1 years, median AHI was 15.0/h, median BMI was 30 kg/m2, 70.2% were male and 29% of patients worked in physical or manual related occupations. 78 patients (7.03%) suffered 140 OI in the 5 years after PSG. In a multivariate logistic regression model, OSA severity [defined as a log(AHI + 1)] was a significant predictor of OI (p = 0.04) after controlling for age, sex, BMI, and physical or manual related occupations. Patients with moderate and severe OSA had approximately two times the odds of an OI compared to patients without OSA (OR 1.99, 95% CI 0.96–4.44 and 2.00, 95% CI 0.96–4.49 for moderate and severe OSA groups, respectively).
ConclusionsIn this prospective study, OSA severity was independently associated with an increased risk of OI.
相似文献OBJECTIVES
- ? To report the outcome of robotic‐assisted laparoscopic radical prostatectomy (RALP) for men with localised high‐risk prostate cancer at diagnosis.
- ? Although commonly managed by radiotherapy (RT) with prolonged androgen‐deprivation therapy (ADT), we hypothesize that initiation of multimodal therapy with RALP is oncologically efficacious and may allow many men to avoid ADT.
PATIENTS AND METHODS
- ? Between December 2003 and September 2010, 1480 men underwent RALP of whom 160 fulfilled the National Comprehensive Control Network criteria for high‐risk disease (prostate‐specific antigen (PSA) >20 ng/mL and/or clinical stage, cT ≥ 3 and/or biopsy Gleason score ≥8).
- ? Biochemical recurrence (postoperative PSA ≥ 0.2) was used to assess outcome after RALP monotherapy.
- ? Treatment failure was defined as either a rising PSA level after salvage RT or the initiation of ADT.
RESULTS
- ? The mean age ± standard deviation was 63.1 ± 6.3 years. Median PSA level was 9.95 ng/mL (interquartile range 6.0–21.4).
- ? Analysis of prostatectomy specimen showed Gleason 8–10 cancers in 65 (41%), and extracapsular disease, pT ≥ 3, in 96 (60%) of which seminal vesicle invasion was evident in 36 (23%). Downgrading by prostatectomy occurred in 64 (40% of total group) and five (3%) were downstaged to pT2 disease. By contrast, any upgrading occurred in 29 (18% of total group) and upstaging occurred in 68 (43%). The overall positive surgical margin rate was 38%, correlating with stage pT2 (15%) or pT3 (53%).
- ? With median follow‐up of 26.2 months (interquartile range 5.5–37.3), two non‐cancer‐related deaths have occurred (overall survival 98.8%; cancer‐specific survival 100%), and biochemical recurrence has occurred in 53 men (33%). RALP surgery has served as monotherapy (n= 117, 73%), or has been followed by salvage RT (n= 24, 15%) and/or ADT (n= 43, 27%). Overall 2‐year and 3‐year treatment failure was 31 and 41%, respectively.
- ? Serum PSA level was the only independent predictor of overall treatment failure (hazard ratio [HR] 1.02, P= 0.001) although a strong trend was observed for both clinical stage (HR 1.22, P= 0.058) and the number of positive biopsy cores on transrectal biopsy (HR 1.06, P= 0.057).
CONCLUSIONS
- ? RALP incorporating the use of postoperative RT is a good multimodal management strategy for men with this aggressive variant of prostate cancer.
- ? At median follow‐up in excess of 2 years, we found low rates of treatment failure enabling a high proportion of men to remain free of ADT.